Glucomannan Inulin Complex Powder (II)

Natural health product licensed in Canada

Other names

MoJu FuHe ChongJi (II)

Licence holder

Nanjing Xiyuan Bio-Pharmaceutical Technology Co. Ltd.

NPN or DIN-HM

80091175

Status

Active licence

Licence date

12 March 2019

Revision date

23 September 2026

Form

Poudre

Route of administration

Orale

Application type

Non traditionnelle

Composition

Non-medicinal ingredients

Poudre de miel, Saveur de pêche, Poudre de germe de sarrasin, Sorbitol, Son d'Avena sativa (Avoine), D-Fructose

Recommended doses in Canada

Uses authorised in Canada

(1) (Used in Herbal Medicine as a) bulk-forming laxative. (2) (Used in Herbal Medicine to) promote(s) bowel movements by increasing bulk volume and water content. (3) (Used in Herbal Medicine to) provide(s) gentle relief of constipation and/or irregularity. (4) Source of fiber for the maintenance of good health. (5) Helps support and maintain a healthy digestive system. (6) Helps provide gentle relief of constipation and/or irregularity. (7) Helps in the development and maintenance of bones, cartilage, teeth and/or gums. (8) Helps in connective tissue formation. (9) Helps in wound healing. (10) Source of/An antioxidant for the maintenance of good health. (11) Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. (12) Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. (13) Helps to maintain immune function. (14) Helps to maintain the body's ability to metabolize nutrients.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

• Effets indésirables connus

  (1) If you experience chest pain, vomiting, or difficulty swallowing or breathing after taking the product, seek immediate medical attention. (2) Loose stools, flatulence, diarrhea, and abdominal discomfort have been reported. (3) Hypersensitivity is known to occur, in which case, discontinue use.

• Précautions et mises en garde

  (1) Consult a health care practitioner prior to use if you have diabetes. (2) Laxative; Promote bowel movement; Constipation relief: Consult a health care practitioner if symptoms worsen or if laxative effect does not occur within seven(7) days. (3) Laxative; Promote bowel movement; Constipation relief: Consult a health care practitioner prior to use if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis). (4) If you are taking medications which inhibit peristaltic movement, consult a health care practitioner prior to use. (5) If you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or have failed to defecate following the use of a laxative product, consult a health care practitioner prior to use. (6) Consult a health care practitioner prior to use if you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. (7) Consult a health care practitioner prior to use if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications. (8) Consult a health care practitioner prior to use if you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever. (9) Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea. (10) If you have a liver disease, a kidney disease, or a seizure disorder, consult a healthcare practitioner prior to use. (11) If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. (12) If you are taking prescription medications, consult a health care practitioner prior to use.

• Contre-indications

  (1) Do not use if you have difficulty swallowing. (2) Do not use if you are pregnant or breastfeeding. (3) Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn's disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes.

Source

Official Health Canada record, licence 80091175

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 23 September 2026 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.